Safety and warning
Instructions for use • EasyGO! II • UYJ889_EN_V2.0_02-2022_IFU_CE-MDR
7
3 Safety and warning
WARNING
Danger due to non-observance of warnings and safety notes
This chapter contains warnings and safety notes structured according to hazards and risks.
1. Carefully read and observe all warnings and safety notes.
2. Follow the instructions.
3.1 Serious incidents
A ‘serious incident’ includes incidents which, directly or indirectly, had, could have had or
could have any of the following consequences:
–
Death of a patient, user, or another person
–
Temporary or permanent serious deterioration in the medical condition of a patient, user,
or another person
–
A serious threat to public health
The manufacturer and appropriate authority must be notified of all serious incidents.
3.2 Correct handling and product testing
If the product is not handled correctly, patients, users, and third parties may be injured.
Only persons with the necessary medical qualification and who are acquainted with the
application of the product may work with it.
Check that the product is suitable for the procedure prior to use.
Check the product for the following properties, for example, before and after every use:
–
Functionality
–
Damage
–
Changes to the surface
–
In the case of several components: completeness and correct assembly
Do not continue to use damaged products.
Dispose of the product properly.
Do not leave broken-off components inside the patient.
Do not overload the product with mechanical stress.
Do not bend bent products back to their original position.
3.3 Unsterile product
The product is not sterile when delivered. The use of non-sterile products poses a risk of
infection for patients, users, and third parties.
Reprocess the product in line with the reprocessing instructions before initial use and
every subsequent use.
3.4 Creutzfeldt-Jakob disease
Products that come into contact with the central nervous system can become contaminated by
organic residue containing prions. Prions lead to infection with Creutzfeldt-Jakob disease.
If Creutzfeldt-Jakob disease has been diagnosed or is suspected:
Do not continue to use the product.
Содержание EasyGO! II
Страница 1: ...Instructions for use EasyGO II en...
Страница 21: ...Subsidiaries Instructions for use EasyGO II UYJ889_EN_V2 0_02 2022_IFU_CE MDR 21...
Страница 22: ...Subsidiaries Instructions for use EasyGO II UYJ889_EN_V2 0_02 2022_IFU_CE MDR 22...
Страница 23: ...Subsidiaries Instructions for use EasyGO II UYJ889_EN_V2 0_02 2022_IFU_CE MDR 23...